Insulin may directly impact breast cancer risk by mitogenic properties, increasing IGF-I secretion and decreasing IGF-I binding proteins [15], inhibiting sex hormone-binding protein (SHBG) synthesis, and raising bioavailable estrogen levels [16]. Here, SHBG is linked to breast carcinoma.